Results after mitral valve replacement with cloth-covered Starr-Edwards prostheses (models 6300, 6310/6320, and 6400)

Robert Forman, W. Beck, C. N. Barnard

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The actuarial survival and thromboembolic rates for the three types of cloth-covered Starr-Edwards mitral prostheses, models 6300, 6310/6320, and 6400 followed 6, 5, and 2 years, respectively, were not significantly different throughout the years they were followed. The combined cumulative survival and thromboembolic proportion at 5 years for these prostheses were 71 and 66 per cent, respectively. The thromboembolic rates were not different in the following two groups: 238 patients receiving anticoagulants, and 52 patients who had discontinued or who were not receiving anticoagulants. Four patients thrombosed their mitral prostheses. Another 8 per cent had class 3 symptoms after operation, which were attributed to myopathic or restrictive left ventricular dysfunction or other valvular disease.

Original languageEnglish (US)
Pages (from-to)612-616
Number of pages5
JournalBritish Heart Journal
Volume40
Issue number6
StatePublished - 1978
Externally publishedYes

Fingerprint

Mitral Valve
Prostheses and Implants
Anticoagulants
Left Ventricular Dysfunction
Thrombosis
Survival Rate
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Results after mitral valve replacement with cloth-covered Starr-Edwards prostheses (models 6300, 6310/6320, and 6400). / Forman, Robert; Beck, W.; Barnard, C. N.

In: British Heart Journal, Vol. 40, No. 6, 1978, p. 612-616.

Research output: Contribution to journalArticle

@article{c64944772c024d659da6943a5c23e554,
title = "Results after mitral valve replacement with cloth-covered Starr-Edwards prostheses (models 6300, 6310/6320, and 6400)",
abstract = "The actuarial survival and thromboembolic rates for the three types of cloth-covered Starr-Edwards mitral prostheses, models 6300, 6310/6320, and 6400 followed 6, 5, and 2 years, respectively, were not significantly different throughout the years they were followed. The combined cumulative survival and thromboembolic proportion at 5 years for these prostheses were 71 and 66 per cent, respectively. The thromboembolic rates were not different in the following two groups: 238 patients receiving anticoagulants, and 52 patients who had discontinued or who were not receiving anticoagulants. Four patients thrombosed their mitral prostheses. Another 8 per cent had class 3 symptoms after operation, which were attributed to myopathic or restrictive left ventricular dysfunction or other valvular disease.",
author = "Robert Forman and W. Beck and Barnard, {C. N.}",
year = "1978",
language = "English (US)",
volume = "40",
pages = "612--616",
journal = "Heart",
issn = "1355-6037",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Results after mitral valve replacement with cloth-covered Starr-Edwards prostheses (models 6300, 6310/6320, and 6400)

AU - Forman, Robert

AU - Beck, W.

AU - Barnard, C. N.

PY - 1978

Y1 - 1978

N2 - The actuarial survival and thromboembolic rates for the three types of cloth-covered Starr-Edwards mitral prostheses, models 6300, 6310/6320, and 6400 followed 6, 5, and 2 years, respectively, were not significantly different throughout the years they were followed. The combined cumulative survival and thromboembolic proportion at 5 years for these prostheses were 71 and 66 per cent, respectively. The thromboembolic rates were not different in the following two groups: 238 patients receiving anticoagulants, and 52 patients who had discontinued or who were not receiving anticoagulants. Four patients thrombosed their mitral prostheses. Another 8 per cent had class 3 symptoms after operation, which were attributed to myopathic or restrictive left ventricular dysfunction or other valvular disease.

AB - The actuarial survival and thromboembolic rates for the three types of cloth-covered Starr-Edwards mitral prostheses, models 6300, 6310/6320, and 6400 followed 6, 5, and 2 years, respectively, were not significantly different throughout the years they were followed. The combined cumulative survival and thromboembolic proportion at 5 years for these prostheses were 71 and 66 per cent, respectively. The thromboembolic rates were not different in the following two groups: 238 patients receiving anticoagulants, and 52 patients who had discontinued or who were not receiving anticoagulants. Four patients thrombosed their mitral prostheses. Another 8 per cent had class 3 symptoms after operation, which were attributed to myopathic or restrictive left ventricular dysfunction or other valvular disease.

UR - http://www.scopus.com/inward/record.url?scp=0017822869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017822869&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 612

EP - 616

JO - Heart

JF - Heart

SN - 1355-6037

IS - 6

ER -